SCOTT ZEILSTRA: Open Payments
NPI 1174963490 · EAST LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,587 in 136 payments from 23 companies in 2025. Trend: 2023 $1,821 · 2024 $2,654 · 2025 $2,587
Food & beverage: $2,525Education: $61
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $589 |
| Janssen Biotech, Inc. | 14 | $314 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $246 |
| Lilly USA, LLC | 10 | $203 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $189 |
| PFIZER INC. | 8 | $159 |
| QOL Medical, LLC | 5 | $124 |
| Ardelyx, Inc. | 6 | $115 |
| Regeneron Healthcare Solutions, Inc. | 4 | $103 |
| Aimmune Therapeutics, Inc. | 4 | $82 |
Products named: TREMFYA, RINVOQ, XIFAXAN, OMVOH, CREON, ENTYVIO, LINZESS, Sucraid.
Industry payments across MI — which companies pay providers there.
